Peter Wells, MD
Clinical Cardiac Electrophysiology · Dallas, TXNPI 1790733103
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $4,500 of the $7,143 with a category attached, or 63.0%. Medtronic accounts for 73.9% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2022 at $3,229 and has fallen 99.2% since, to $27 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in TX, where the typical reported total is $27,892.
Across 104 payments — averaging $68.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$5K
- Abbott$1K
- Boston Scientific$293
- Biosense Webster, Inc.$42
- E.r. Squibb & Sons, L.L.C.$40
- Cardiva Medical, Inc.$28
- plus $177 from 10 others
Across 6 payments — averaging $1414.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$8K
What the payments were for
- Speaking & faculty fees$4,50063%
- Food & beverage$2,64337%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 32 | $5,282 |
| Abbott | 44 | $1,282 |
| Boston Scientific | 13 | $293 |
| Biosense Webster, Inc. | 1 | $42 |
| E.r. Squibb & Sons, L.L.C. | 2 | $40 |
| Cardiva Medical, Inc. | 1 | $28 |
| Sanofi-aventis U.S. LLC | 2 | $26 |
| Johnson & Johnson | 1 | $24 |
| Boehringer Ingelheim | 1 | $19 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $19 |
| Biotronik Inc. | 1 | $17 |
| Pfizer | 1 | $17 |
| Novartis | 1 | $15 |
| Amarin Pharma, Inc. | 1 | $14 |
| G Medical Diagnostic Services, Inc. | 1 | $13 |
| Cook Medical LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Arctic Front$1,800
- Micra$116
- Capsure$114
How this compares
$7,143 in reported general payments places this provider in the 15th percentile of 233 clinical cardiac electrophysiology providers in Texas.
See all clinical cardiac electrophysiology providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 90 | $97,051 |
| XareltoRivaroxaban | 20 | $17,230 |
| Flecainide Acetate | 59 | $3,030 |
| Amiodarone Hcl | 14 | $365 |
| Metoprolol Succinate | 22 | $178 |
| Metoprolol Tartrate | 29 | $115 |
| Atenolol | 11 | $5 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $17 | $97,05190 claims |
| Johnson & JohnsonXarelto | $24 | $17,23020 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 15th percentile of 233 clinical cardiac electrophysiology providers in Texas.
Other clinical cardiac electrophysiology in Dallas
- Russell CanhamDallas$184K
- Mustafa DohadwalaDallas$121K
- Usama DaimeeDallas$102K
- Brian leDallas$102K
- Mohammad ShaarDallas$87K
- Praveen RaoDallas$67K
- Michael DelaughterBedford$1.6M
- Andrea NataleAustin$1.3M
- Jason ZagrodzkyAustin$961K
- Amin Al-AhmadAustin$771K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.